The increasing resistance of many microbial strains to antibiotics, delayed laboratory results, and side effects of many chemotherapeutics has raised the need to search for sensitive diagnostics and new prophylactic strategies especially prevention by vaccination. Understanding the epitope/antibody interaction is the key to constructing potent vaccines and effective diagnostics. B-cell epitope mapping is a promising…
Trials in Vaccinology Template
Write in a clean editor, then format for Trials in Vaccinology in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Trials in Vaccinology format
Trials in Vaccinology is a peer-reviewed journal published by Elsevier, covering Viral gastroenteritis research and epidemiology, Influenza Virus Research Studies, Viral Infections and Immunology Research.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Trials in Vaccinology 12 (2023) 45–58.
Formats any DOI in Trials in Vaccinology style. No sign-up. |
| Publishes research in | Viral gastroenteritis research and epidemiology Influenza Virus Research Studies Viral Infections and Immunology Research Virus-based gene therapy research Respiratory viral infections research |
| ISSN | 1879-4378 |
| h-index | 18 |
| i10-index | 43 |
| Total citations | 1,153 |
| Top institutions publishing here | Zoetis (United States) |
| Journal website | www.sciencedirect.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Trials in Vaccinology per year
Citation impact of Trials in Vaccinology by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Trials in Vaccinology
The Community Acquired Pneumonia immunization Trial in Adults (CAPiTA) was conducted to evaluate 13-valent pneumococcal conjugate vaccine (PCV13) for the prevention of vaccine-type community-acquired pneumonia (VT-CAP) and vaccine-type invasive pneumococcal disease (VT-IPD) in adults aged ⩾65 years. Plotting the cumulative number of episodes against time from vaccination demonstrated that efficacy was evident soon after vaccination…
Coccidiosis is a major intestinal disease affecting economically valuable livestock animals such as chickens and turkeys. Economic losses are associated with decreased productivity in afflicted animals. The different Eimeria spp. are the main etiologic agents for that virulent disease. The usefulness of prophylactic and therapeutic anticoccidial compounds has decreased in recent years due to the…
Acinetobacter baumannii has recently crossed all lines once considered harmless, pushing its way as a nosocomial pathogen. It had acquired resistance to almost all available chemotherapies and mainly targets intensive care residents; causing pneumonia and major outbreaks with high mortality rates. This urged the need for preventive methods, which include infection control, non-specific immune-therapy, passive,…
Neonatal Bacille Calmette Guérin (BCG) vaccination has been reported to have beneficial effects beyond preventing infantile tuberculous meningitis and miliary disease. We hypothesized that BCG vaccine given at birth would enhance T-helper 1 (Th1) immune responses to the first vaccines given later in infancy. We conducted a nested case-control study of neonatal BCG vaccination and…